Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs Dapagliflozin (Primary) ; Acetazolamide
- Indications Heart failure
- Focus Therapeutic Use
- 23 Jan 2025 New trial record